Click for best price

RNAbased Biopharmaceuticals Market Size, Share 2022

Market Analysis and Insights: Global RNAbased Biopharmaceuticals Market

The global RNAbased Biopharmaceuticals market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNAbased Biopharmaceuticals market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNAbased Biopharmaceuticals market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNAbased Biopharmaceuticals market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNAbased Biopharmaceuticals market.

Global RNAbased Biopharmaceuticals Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Therapeutics

Vaccines

Segment by Application

Cancer

Diabetes

Tuberculosis

Cardiovascular Diseases

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Pfizer

Roche

Sanofi-Aventis

Abbott Laboratories

Arrowhead Pharmaceuticals

Benitec Biopharma

Calimmune Inc

Dicerna

Gradalis

Quark

RXi

Senesco

Silence Therapeutics

Silenseed

Tekmira

Alnylam Pharmaceuticals

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes RNAbased Biopharmaceuticals product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of RNAbased Biopharmaceuticals, with price, sales, revenue, and global market share of RNAbased Biopharmaceuticals from 2019 to 2022.

Chapter 3, the RNAbased Biopharmaceuticals competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the RNAbased Biopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the RNAbased Biopharmaceuticals market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of RNAbased Biopharmaceuticals.

Chapter 13, 14, and 15, to describe RNAbased Biopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 RNAbased Biopharmaceuticals Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global RNA-based Biopharmaceuticals Market Research Report 2023
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	107 Pages
Customization Available	Yes, the report can be customized as per your need.

1 RNA-based Biopharmaceuticals Market Overview
1.1 Product Overview and Scope of RNA-based Biopharmaceuticals
1.2 RNA-based Biopharmaceuticals Segment by Type
1.2.1 Global RNA-based Biopharmaceuticals Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Therapeutics
1.2.3 Vaccines
1.3 RNA-based Biopharmaceuticals Segment by Application
1.3.1 Global RNA-based Biopharmaceuticals Sales Comparison by Application: (2023-2030)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA-based Biopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global RNA-based Biopharmaceuticals Revenue 2018-2030
1.4.2 Global RNA-based Biopharmaceuticals Sales 2018-2030
1.4.3 RNA-based Biopharmaceuticals Market Size by Region: 2018 Versus 2022 Versus 2030
2 RNA-based Biopharmaceuticals Market Competition by Manufacturers
2.1 Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
2.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Manufacturers (2018-2023)
2.3 Global RNA-based Biopharmaceuticals Average Price by Manufacturers (2018-2023)
2.4 Manufacturers RNA-based Biopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 RNA-based Biopharmaceuticals Market Competitive Situation and Trends
2.5.1 RNA-based Biopharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest RNA-based Biopharmaceuticals Players Market Share by Revenue
2.5.3 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RNA-based Biopharmaceuticals Retrospective Market Scenario by Region
3.1 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global RNA-based Biopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.3.1 North America RNA-based Biopharmaceuticals Sales by Country
3.3.2 North America RNA-based Biopharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe RNA-based Biopharmaceuticals Sales by Country
3.4.2 Europe RNA-based Biopharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific RNA-based Biopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific RNA-based Biopharmaceuticals Sales by Region
3.5.2 Asia Pacific RNA-based Biopharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America RNA-based Biopharmaceuticals Sales by Country
3.6.2 Latin America RNA-based Biopharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa RNA-based Biopharmaceuticals Sales by Country
3.7.2 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global RNA-based Biopharmaceuticals Historic Market Analysis by Type
4.1 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2018-2023)
4.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2018-2023)
4.3 Global RNA-based Biopharmaceuticals Price by Type (2018-2023)
5 Global RNA-based Biopharmaceuticals Historic Market Analysis by Application
5.1 Global RNA-based Biopharmaceuticals Sales Market Share by Application (2018-2023)
5.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2018-2023)
5.3 Global RNA-based Biopharmaceuticals Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer RNA-based Biopharmaceuticals Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche RNA-based Biopharmaceuticals Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi-Aventis
6.3.1 Sanofi-Aventis Corporation Information
6.3.2 Sanofi-Aventis Description and Business Overview
6.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Product Portfolio
6.3.5 Sanofi-Aventis Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Arrowhead Pharmaceuticals
6.5.1 Arrowhead Pharmaceuticals Corporation Information
6.5.2 Arrowhead Pharmaceuticals Description and Business Overview
6.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Portfolio
6.5.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.6 Benitec Biopharma
6.6.1 Benitec Biopharma Corporation Information
6.6.2 Benitec Biopharma Description and Business Overview
6.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Product Portfolio
6.6.5 Benitec Biopharma Recent Developments/Updates
6.7 Calimmune Inc
6.6.1 Calimmune Inc Corporation Information
6.6.2 Calimmune Inc Description and Business Overview
6.6.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Calimmune Inc RNA-based Biopharmaceuticals Product Portfolio
6.7.5 Calimmune Inc Recent Developments/Updates
6.8 Dicerna
6.8.1 Dicerna Corporation Information
6.8.2 Dicerna Description and Business Overview
6.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dicerna RNA-based Biopharmaceuticals Product Portfolio
6.8.5 Dicerna Recent Developments/Updates
6.9 Gradalis
6.9.1 Gradalis Corporation Information
6.9.2 Gradalis Description and Business Overview
6.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gradalis RNA-based Biopharmaceuticals Product Portfolio
6.9.5 Gradalis Recent Developments/Updates
6.10 Quark
6.10.1 Quark Corporation Information
6.10.2 Quark Description and Business Overview
6.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Quark RNA-based Biopharmaceuticals Product Portfolio
6.10.5 Quark Recent Developments/Updates
6.11 RXi
6.11.1 RXi Corporation Information
6.11.2 RXi RNA-based Biopharmaceuticals Description and Business Overview
6.11.3 RXi RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.11.4 RXi RNA-based Biopharmaceuticals Product Portfolio
6.11.5 RXi Recent Developments/Updates
6.12 Senesco
6.12.1 Senesco Corporation Information
6.12.2 Senesco RNA-based Biopharmaceuticals Description and Business Overview
6.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Senesco RNA-based Biopharmaceuticals Product Portfolio
6.12.5 Senesco Recent Developments/Updates
6.13 Silence Therapeutics
6.13.1 Silence Therapeutics Corporation Information
6.13.2 Silence Therapeutics RNA-based Biopharmaceuticals Description and Business Overview
6.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Product Portfolio
6.13.5 Silence Therapeutics Recent Developments/Updates
6.14 Silenseed
6.14.1 Silenseed Corporation Information
6.14.2 Silenseed RNA-based Biopharmaceuticals Description and Business Overview
6.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Silenseed RNA-based Biopharmaceuticals Product Portfolio
6.14.5 Silenseed Recent Developments/Updates
6.15 Tekmira
6.15.1 Tekmira Corporation Information
6.15.2 Tekmira RNA-based Biopharmaceuticals Description and Business Overview
6.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tekmira RNA-based Biopharmaceuticals Product Portfolio
6.15.5 Tekmira Recent Developments/Updates
6.16 Alnylam Pharmaceuticals
6.16.1 Alnylam Pharmaceuticals Corporation Information
6.16.2 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Description and Business Overview
6.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Portfolio
6.16.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 RNA-based Biopharmaceuticals Manufacturing Cost Analysis
7.1 RNA-based Biopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of RNA-based Biopharmaceuticals
7.4 RNA-based Biopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 RNA-based Biopharmaceuticals Distributors List
8.3 RNA-based Biopharmaceuticals Customers
9 RNA-based Biopharmaceuticals Market Dynamics
9.1 RNA-based Biopharmaceuticals Industry Trends
9.2 RNA-based Biopharmaceuticals Market Drivers
9.3 RNA-based Biopharmaceuticals Market Challenges
9.4 RNA-based Biopharmaceuticals Market Restraints
10 Global Market Forecast
10.1 RNA-based Biopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of RNA-based Biopharmaceuticals by Type (2023-2030)
10.1.2 Global Forecasted Revenue of RNA-based Biopharmaceuticals by Type (2023-2030)
10.2 RNA-based Biopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of RNA-based Biopharmaceuticals by Application (2023-2030)
10.2.2 Global Forecasted Revenue of RNA-based Biopharmaceuticals by Application (2023-2030)
10.3 RNA-based Biopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of RNA-based Biopharmaceuticals by Region (2023-2030)
10.3.2 Global Forecasted Revenue of RNA-based Biopharmaceuticals by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global RNA-based Biopharmaceuticals Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global RNA-based Biopharmaceuticals Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global RNA-based Biopharmaceuticals Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global RNA-based Biopharmaceuticals Market Competitive Situation by Manufacturers in 2022
Table 5. Global RNA-based Biopharmaceuticals Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
Table 7. Global RNA-based Biopharmaceuticals Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market RNA-based Biopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers RNA-based Biopharmaceuticals Manufacturing Sites and Area Served
Table 11. Manufacturers RNA-based Biopharmaceuticals Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global RNA-based Biopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA-based Biopharmaceuticals as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global RNA-based Biopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 16. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2018-2023)
Table 17. Global RNA-based Biopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2018-2023)
Table 19. North America RNA-based Biopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 20. North America RNA-based Biopharmaceuticals Sales Market Share by Country (2018-2023)
Table 21. North America RNA-based Biopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America RNA-based Biopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 23. Europe RNA-based Biopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 24. Europe RNA-based Biopharmaceuticals Sales Market Share by Country (2018-2023)
Table 25. Europe RNA-based Biopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe RNA-based Biopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific RNA-based Biopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific RNA-based Biopharmaceuticals Revenue Market Share by Region (2018-2023)
Table 31. Latin America RNA-based Biopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 32. Latin America RNA-based Biopharmaceuticals Sales Market Share by Country (2018-2023)
Table 33. Latin America RNA-based Biopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America RNA-based Biopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa RNA-based Biopharmaceuticals Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa RNA-based Biopharmaceuticals Revenue Market Share by Country (2018-2023)
Table 39. Global RNA-based Biopharmaceuticals Sales by Type (2018-2023) & (K Units)
Table 40. Global RNA-based Biopharmaceuticals Sales Market Share by Type (2018-2023)
Table 41. Global RNA-based Biopharmaceuticals Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global RNA-based Biopharmaceuticals Revenue Share by Type (2018-2023)
Table 43. Global RNA-based Biopharmaceuticals Price by Type (2018-2023) & (USD/Unit)
Table 44. Global RNA-based Biopharmaceuticals Sales (K Units) by Application (2018-2023)
Table 45. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2018-2023)
Table 46. Global RNA-based Biopharmaceuticals Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global RNA-based Biopharmaceuticals Revenue Share by Application (2018-2023)
Table 48. Global RNA-based Biopharmaceuticals Price by Application (2018-2023) & (USD/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Pfizer RNA-based Biopharmaceuticals Product
Table 53. Pfizer Recent Developments/Updates
Table 54. Roche Corporation Information
Table 55. Roche Description and Business Overview
Table 56. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Roche RNA-based Biopharmaceuticals Product
Table 58. Roche Recent Developments/Updates
Table 59. Sanofi-Aventis Corporation Information
Table 60. Sanofi-Aventis Description and Business Overview
Table 61. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Sanofi-Aventis RNA-based Biopharmaceuticals Product
Table 63. Sanofi-Aventis Recent Developments/Updates
Table 64. Abbott Laboratories Corporation Information
Table 65. Abbott Laboratories Description and Business Overview
Table 66. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Abbott Laboratories RNA-based Biopharmaceuticals Product
Table 68. Abbott Laboratories Recent Developments/Updates
Table 69. Arrowhead Pharmaceuticals Corporation Information
Table 70. Arrowhead Pharmaceuticals Description and Business Overview
Table 71. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product
Table 73. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 74. Benitec Biopharma Corporation Information
Table 75. Benitec Biopharma Description and Business Overview
Table 76. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Benitec Biopharma RNA-based Biopharmaceuticals Product
Table 78. Benitec Biopharma Recent Developments/Updates
Table 79. Calimmune Inc Corporation Information
Table 80. Calimmune Inc Description and Business Overview
Table 81. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Calimmune Inc RNA-based Biopharmaceuticals Product
Table 83. Calimmune Inc Recent Developments/Updates
Table 84. Dicerna Corporation Information
Table 85. Dicerna Description and Business Overview
Table 86. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Dicerna RNA-based Biopharmaceuticals Product
Table 88. Dicerna Recent Developments/Updates
Table 89. Gradalis Corporation Information
Table 90. Gradalis Description and Business Overview
Table 91. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Gradalis RNA-based Biopharmaceuticals Product
Table 93. Gradalis Recent Developments/Updates
Table 94. Quark Corporation Information
Table 95. Quark Description and Business Overview
Table 96. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Quark RNA-based Biopharmaceuticals Product
Table 98. Quark Recent Developments/Updates
Table 99. RXi Corporation Information
Table 100. RXi Description and Business Overview
Table 101. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. RXi RNA-based Biopharmaceuticals Product
Table 103. RXi Recent Developments/Updates
Table 104. Senesco Corporation Information
Table 105. Senesco Description and Business Overview
Table 106. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Senesco RNA-based Biopharmaceuticals Product
Table 108. Senesco Recent Developments/Updates
Table 109. Silence Therapeutics Corporation Information
Table 110. Silence Therapeutics Description and Business Overview
Table 111. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Silence Therapeutics RNA-based Biopharmaceuticals Product
Table 113. Silence Therapeutics Recent Developments/Updates
Table 114. Silenseed Corporation Information
Table 115. Silenseed Description and Business Overview
Table 116. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Silenseed RNA-based Biopharmaceuticals Product
Table 118. Silenseed Recent Developments/Updates
Table 119. Tekmira Corporation Information
Table 120. Tekmira Description and Business Overview
Table 121. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Tekmira RNA-based Biopharmaceuticals Product
Table 123. Tekmira Recent Developments/Updates
Table 124. Alnylam Pharmaceuticals Corporation Information
Table 125. Alnylam Pharmaceuticals Description and Business Overview
Table 126. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product
Table 128. Alnylam Pharmaceuticals Recent Developments/Updates
Table 129. Production Base and Market Concentration Rate of Raw Material
Table 130. Key Suppliers of Raw Materials
Table 131. RNA-based Biopharmaceuticals Distributors List
Table 132. RNA-based Biopharmaceuticals Customers List
Table 133. RNA-based Biopharmaceuticals Market Trends
Table 134. RNA-based Biopharmaceuticals Market Drivers
Table 135. RNA-based Biopharmaceuticals Market Challenges
Table 136. RNA-based Biopharmaceuticals Market Restraints
Table 137. Global RNA-based Biopharmaceuticals Sales Forecast by Type (2023-2030) & (K Units)
Table 138. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Type (2023-2030)
Table 139. Global RNA-based Biopharmaceuticals Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 140. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Type (2023-2030)
Table 141. Global RNA-based Biopharmaceuticals Sales Forecast by Application (2023-2030) & (K Units)
Table 142. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Application (2023-2030)
Table 143. Global RNA-based Biopharmaceuticals Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 144. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Application (2023-2030)
Table 145. Global RNA-based Biopharmaceuticals Sales Forecast by Region (2023-2030) & (K Units)
Table 146. Global RNA-based Biopharmaceuticals Sales Market Share Forecast by Region (2023-2030)
Table 147. Global RNA-based Biopharmaceuticals Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 148. Global RNA-based Biopharmaceuticals Revenue Market Share Forecast by Region (2023-2030)
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of RNA-based Biopharmaceuticals
Figure 2. Global RNA-based Biopharmaceuticals Market Share by Type in 2022 & 2030
Figure 3. Therapeutics Product Picture
Figure 4. Vaccines Product Picture
Figure 5. Global RNA-based Biopharmaceuticals Market Share by Application in 2022 & 2030
Figure 6. Cancer
Figure 7. Diabetes
Figure 8. Tuberculosis
Figure 9. Cardiovascular Diseases
Figure 10. Others
Figure 11. Global RNA-based Biopharmaceuticals Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 12. Global RNA-based Biopharmaceuticals Market Size (2018-2030) & (US$ Million)
Figure 13. Global RNA-based Biopharmaceuticals Sales (2018-2030) & (K Units)
Figure 14. RNA-based Biopharmaceuticals Sales Share by Manufacturers in 2022
Figure 15. Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers in 2022
Figure 16. The Global 5 and 10 Largest RNA-based Biopharmaceuticals Players: Market Share by Revenue in 2022
Figure 17. RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 18. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2018-2023)
Figure 19. Global RNA-based Biopharmaceuticals Sales Market Share by Region in 2022
Figure 20. Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2018-2023)
Figure 21. Global RNA-based Biopharmaceuticals Revenue Market Share by Region in 2022
Figure 22. U.S. RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. Canada RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. Germany RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. France RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. U.K. RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Italy RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Russia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. China RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. Japan RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. South Korea RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. India RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Australia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Taiwan RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Indonesia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Thailand RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Malaysia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Philippines RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Vietnam RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Mexico RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Brazil RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Argentina RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Turkey RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Saudi Arabia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. U.A.E RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Sales Market Share of RNA-based Biopharmaceuticals by Type (2018-2023)
Figure 47. Manufacturing Cost Structure of RNA-based Biopharmaceuticals
Figure 48. Manufacturing Process Analysis of RNA-based Biopharmaceuticals
Figure 49. RNA-based Biopharmaceuticals Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global RNA-based Biopharmaceuticals Market Research Report 2023